PRRT2 and breast carcinoma: Furthermore, PKC genes are frequently mutated, especially in human cancers, with 20–25% of the mutations detected in melanoma, colorectal cancer and lung squamous cell carcinoma, whereas less than 5% are found in glioblastoma, ovarian and breast cancer [24].